- Telehealth Visits
- Insurance plan information
Ken Nakamura, MD, PhD
Movement Disorders Neurology • Neurology- Telehealth Visits
- Insurance plan information
Ken Nakamura, MD, PhD
Movement Disorders Neurology • Neurology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Ken Nakamura is a neurologist who specializes in diagnosing and treating patients with Parkinson's disease at the Parkinson's Disease and Movement Disorders Clinic. He also runs a research laboratory at the Gladstone Institutes, where he investigates how disruptions of mitochondria – the ""power centers"" of cells that convert nutrients into energy – contribute to the development and progression of Parkinson's disease and Alzheimer's disease.
Nakamura earned a bachelor's degree in chemistry and biological sciences from Cornell University, and a medical degree and doctorate in neurobiology from the University of Chicago. His thesis work focused on the role of oxidative stress and mitochondrial dysfunction in the manner and development of Parkinson's disease. He completed an internship in internal medicine and a residency in neurology at UCSF, as well as a clinical fellowship in movement disorders at UCSF and the San Francisco Veterans Affairs Medical Center. He also completed a research fellowship at UCSF.
Nakamura has received several awards, including a Career Award for Medical Scientists from the Burroughs Wellcome Fund.
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Residency
- UCSF Medical Center - OMAG
Degree
- MD, University of Chicago Pritzker School of Medicine
My expertise
Specialties
Conditions
- Tardive Dyskinesia
- Progressive Supranuclear Palsy
- Multiple System Atrophy
- Lewy Body Dementia
- Huntington's Disease
- Dystonia
- Chorea
- Parkinson's Disease (PD)
- Essential Tremor
Treatments
Locations
My research
Publications
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.